Treatment of Ductal Carcinoma in Situ
https://www.cancer.org/cancer/breast-cancer/treatment/treatment-of-breast-cancer-by-stage/treatment-of-ductal-carcinoma-in-situ-dcis.html
Treatment of Ductal Carcinoma in Situ (DCIS)
Ductal carcinoma in situ (DCIS) means the cells that line the milk ducts of the breast have become cancer, but they have not spread into surrounding breast tissue.
DCIS is considered non-invasive or pre-invasive breast cancer. DCIS can’t spread outside the breast, but it still needs to be treated because it can sometimes go on to become invasive breast cancer (which can spread).
In most cases, a woman with DCIS can choose between breast-conserving surgery (BCS) and simple mastectomy. But sometimes a mastectomy might be a better option.
Breast-conserving surgery (BCS)
In breast-conserving surgery (BCS), the surgeon removes the tumor and a small amount of normal breast tissue around it. Lymph node removal is not always needed with BCS, but it may be done if the doctor thinks the area of DCIS might also contain invasive cancer. The chances an area of DCIS contains invasive cancer goes up with tumor size and how fast the cancer is growing. If lymph nodes are removed, this is usually done as a sentinel lymph node biopsy (SLNB).
If BCS is done, it is usually followed by radiation therapy. This lowers the chance of the cancer coming back in the same breast (either as more DCIS or as an invasive cancer). BCS without radiation therapy is not a standard treatment, but it might be an option for certain women who had small areas of low-grade DCIS that were removed with large enough cancer-free surgical margins.
Mastectomy
Simple mastectomy (removal of the entire breast) may be needed if the area of DCIS is very large, if the breast has several separate areas of DCIS, or if BCS cannot remove the DCIS completely (that is, the BCS specimen and re-excision specimens still have cancer cells in or near the surgical margins). Many doctors will do a SLNB along with the mastectomy. This is because if an area of invasive cancer is found in the tissue removed during a mastectomy, the doctor won’t be able to go back and do the SLNB later, and so may have to do a full axillary lymph node dissection (ALND).
Women having a mastectomy for DCIS typically don’t need radiation therapy and may choose to have breast reconstruction immediately or later.
Hormone therapy after surgery
If the DCIS is hormone receptor-positive (estrogen or progesterone), treatment with tamoxifen (for any woman) or an aromatase inhibitor (for women past menopause) for 5 years after surgery can lower the risk of another DCIS or invasive cancer developing in either breast. If you have hormone receptor-positive DCIS, discuss the reasons for and against hormone therapy with your doctors.
Written by
References
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators
Treatment of Ductal Carcinoma in Situ (DCIS)
Ductal carcinoma in situ (DCIS) means the cells that line the milk ducts of the breast have become cancer, but they have not spread into surrounding breast tissue.
DCIS is considered non-invasive or pre-invasive breast cancer. DCIS can’t spread outside the breast, but it still needs to be treated because it can sometimes go on to become invasive breast cancer (which can spread).
In most cases, a woman with DCIS can choose between breast-conserving surgery (BCS) and simple mastectomy. But sometimes a mastectomy might be a better option.
Breast-conserving surgery (BCS)
In breast-conserving surgery (BCS), the surgeon removes the tumor and a small amount of normal breast tissue around it. Lymph node removal is not always needed with BCS, but it may be done if the doctor thinks the area of DCIS might also contain invasive cancer. The chances an area of DCIS contains invasive cancer goes up with tumor size and how fast the cancer is growing. If lymph nodes are removed, this is usually done as a sentinel lymph node biopsy (SLNB).
If BCS is done, it is usually followed by radiation therapy. This lowers the chance of the cancer coming back in the same breast (either as more DCIS or as an invasive cancer). BCS without radiation therapy is not a standard treatment, but it might be an option for certain women who had small areas of low-grade DCIS that were removed with large enough cancer-free surgical margins.
Mastectomy
Simple mastectomy (removal of the entire breast) may be needed if the area of DCIS is very large, if the breast has several separate areas of DCIS, or if BCS cannot remove the DCIS completely (that is, the BCS specimen and re-excision specimens still have cancer cells in or near the surgical margins). Many doctors will do a SLNB along with the mastectomy. This is because if an area of invasive cancer is found in the tissue removed during a mastectomy, the doctor won’t be able to go back and do the SLNB later, and so may have to do a full axillary lymph node dissection (ALND).
Women having a mastectomy for DCIS typically don’t need radiation therapy and may choose to have breast reconstruction immediately or later.
Hormone therapy after surgery
If the DCIS is hormone receptor-positive (estrogen or progesterone), treatment with tamoxifen (for any woman) or an aromatase inhibitor (for women past menopause) for 5 years after surgery can lower the risk of another DCIS or invasive cancer developing in either breast. If you have hormone receptor-positive DCIS, discuss the reasons for and against hormone therapy with your doctors.
Written by
References
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators
Transcript
00:00Treatment of Ductal Carcinoma in Situ (DCIS)
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined3
undefined:undefined4
undefined:undefined
undefined:undefinedit still needs to be treated because it can
00:20sometimes go on to become invasive breast
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined8
undefined:undefined9
undefined:undefined
undefined:undefinedIn breast-conserving surgery (BCS), the surgeon
00:40removes the tumor and a small amount of normal
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined13
undefined:undefined
undefined:undefinedcancer goes up with tumor size and how fast
00:56the cancer is growing.
00:57If lymph nodes are removed, this is usually
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined18
undefined:undefined
undefined:undefined
undefined:undefinedtreatment, but it might be an option for certain
01:17women who had small areas of low-grade DCIS
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined24
undefined:undefined
undefined:undefinedDCIS completely (that is, the BCS specimen
01:37and re-excision specimens still have cancer
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined28
undefined:undefined
undefined:undefineddo the SLNB later, and so may have to do a
01:53full axillary lymph node dissection (ALND).
01:57Women having a mastectomy for DCIS typically
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined33
undefined:undefined
undefined:undefined(for any woman) or an aromatase inhibitor
02:13(for women past menopause) for 5 years after
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined00:00:06,839 --> 00:00:10,420
undefined:undefined38
undefined:undefined